BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/22/2022 10:52:23 AM | Browse: 662 | Download: 1755
 |
Received |
|
2021-07-23 10:18 |
 |
Peer-Review Started |
|
2021-07-23 10:26 |
 |
First Decision by Editorial Office Director |
|
2021-09-05 05:46 |
 |
Return for Revision |
|
2021-09-06 11:27 |
 |
Revised |
|
2021-09-17 13:17 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2022-03-22 06:37 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2022-03-27 06:43 |
 |
Articles in Press |
|
2022-03-27 06:43 |
 |
Edit the Manuscript by Language Editor |
|
2022-03-14 10:53 |
 |
Typeset the Manuscript |
|
2022-04-15 06:34 |
 |
Publish the Manuscript Online |
|
2022-04-22 10:52 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Basic Study |
| Article Title |
Baicalin provides protection against fluoxetine-induced hepatotoxicity by modulation of oxidative stress and inflammation
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Risha Ganguly, Ramesh Kumar and Abhay K Pandey |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Abhay K Pandey, PhD, Professor, Department of Biochemistry, University of Allahabad, University Road, Katra, Prayagraj 211002, India. akpandey23@rediffmail.com |
| Key Words |
Fluoxetine; Hepatotoxicity; Oxidative stress; Baicalin; Anti-inflammatory; Hepatoprotective and antioxidant |
| Core Tip |
Prolonged treatment with the antidepressant drug fluoxetine causes severe hepatic damage. This study evaluated fluoxetine-induced liver damage in male albino Wistar rats. Oral fluoxetine was administered (10 mg/kg) for 28 d and caused significant alterations in serum and tissue biomarkers. Baicalin and silymarin were co-administered to facilitate the amelioration of oxidative stress-mediated hepatic damage and inflammation. The biochemical markers (total protein, albumin, total bilirubin, alanine transaminase, aspartate transaminase, alkaline phosphatase, superoxide dismutase, catalase, glutathione, glutathione-S-transferase, malondialdehyde and advanced oxidation protein products) and inflammatory markers [tumor necrosis factor-α, interleukin (IL)-6, IL-10 and interferon-γ] were markedly restored to near normal levels after treatment with the natural flavonoid compound baicalin. Histopathological examination of liver slices showing cellular degeneration and increased vacuolation in the fluoxetine-treated rats also corroborated the results obtained for biomarkers of liver function, oxidative stress and inflammation. The baicalin-treated rats demonstrated normal vacuolation and cellular pattern. Thus, baicalin acts as an antioxidant, anti-inflammatory and hepatoprotective agent in mitigating fluoxetine-induced toxicity. To the best of our knowledge, this is the first study to report the hepatoprotective efficacy of baicalin in fluoxetine-induced liver damage. |
| Publish Date |
2022-04-22 10:52 |
| Citation |
Ganguly R, Kumar R, Pandey AK. Baicalin provides protection against fluoxetine-induced hepatotoxicity by modulation of oxidative stress and inflammation. World J Hepatol 2022; 14(4): 729-743 |
| URL |
https://www.wjgnet.com/1948-5182/full/v14/i4/729.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v14.i4.729 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.